Hugo_Symbol	Entrez_Gene_Id	Center	NCBI_Build	Chromosome	Start_position	End_position	Strand	Variant_Classification	Variant_Type	Reference_Allele	Tumor_Seq_Allele1	Tumor_Seq_Allele2	dbSNP_RS	dbSNP_Val_Status	Tumor_Sample_Barcode	Matched_Norm_Sample_Barcode	Match_Norm_Seq_Allele1	Match_Norm_Seq_Allele2	Tumor_Validation_Allele1	Tumor_Validation_Allele2	Match_Norm_Validation_Allele1	Match_Norm_Validation_Allele2	Verification_Status	Validation_Status	Mutation_Status	Sequencing_Phase	Sequence_Source	Validation_Method	Score	BAM_file	Sequencer	Tumor_Sample_UUID	Matched_Norm_Sample_UUID	Genome_Change	Annotation_Transcript	Transcript_Strand	Transcript_Exon	Transcript_Position	cDNA_Change	Codon_Change	Protein_Change	Other_Transcripts	Refseq_mRNA_Id	Refseq_prot_Id	SwissProt_acc_Id	SwissProt_entry_Id	Description	UniProt_AApos	UniProt_Region	UniProt_Site	UniProt_Natural_Variations	UniProt_Experimental_Info	GO_Biological_Process	GO_Cellular_Component	GO_Molecular_Function	COSMIC_overlapping_mutations	COSMIC_fusion_genes	COSMIC_tissue_types_affected	COSMIC_total_alterations_in_gene	Tumorscape_Amplification_Peaks	Tumorscape_Deletion_Peaks	TCGAscape_Amplification_Peaks	TCGAscape_Deletion_Peaks	DrugBank	ref_context	gc_content	CCLE_ONCOMAP_overlapping_mutations	CCLE_ONCOMAP_total_mutations_in_gene	CGC_Mutation_Type	CGC_Translocation_Partner	CGC_Tumor_Types_Somatic	CGC_Tumor_Types_Germline	CGC_Other_Diseases	DNARepairGenes_Role	FamilialCancerDatabase_Syndromes	MUTSIG_Published_Results	OREGANNO_ID	OREGANNO_Values	t_alt_count	t_ref_count	validation_alt_allele	validation_method	validation_status	validation_tumor_sample
SLC35F3	148641	broad.mit.edu	37	1	234444947	234444947	+	Missense_Mutation	SNP	T	T	G			TCGA-EJ-A7NH-01A-12D-A33T-08	TCGA-EJ-A7NH-10A-01D-A33W-08								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	4e69e7f2-9350-438e-b4c0-66d28d1681a3	ad22411c-0db0-4ad6-8c80-4134cc51e7ed	g.chr1:234444947T>G	ENST00000366618.3	+	4	854	c.709T>G	c.(709-711)Tac>Gac	p.Y237D	SLC35F3_ENST00000366617.3_Missense_Mutation_p.Y168D	NM_173508.2	NP_775779.1	Q8IY50	S35F3_HUMAN	solute carrier family 35, member F3	168					transport	integral to membrane				breast(2)|endometrium(3)|kidney(2)|large_intestine(7)|lung(13)|ovary(2)|skin(2)|urinary_tract(1)	32	Ovarian(103;0.0454)	all_cancers(173;0.145)|Prostate(94;0.0885)	OV - Ovarian serous cystadenocarcinoma(106;0.00531)			AAACTACCTGTACTTACATGC	0.423													8	118	---	---	---	---
ACY1	95	broad.mit.edu	37	3	52012035	52012035	+	Missense_Mutation	SNP	G	G	T			TCGA-EJ-A7NH-01A-12D-A33T-08	TCGA-EJ-A7NH-10A-01D-A33W-08								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	4e69e7f2-9350-438e-b4c0-66d28d1681a3	ad22411c-0db0-4ad6-8c80-4134cc51e7ed	g.chr3:52012035G>T	ENST00000458031.2	+	2	304	c.73G>T	c.(73-75)Gtc>Ttc	p.V25F	ABHD14A-ACY1_ENST00000463937.1_Missense_Mutation_p.G73V|ABHD14B_ENST00000483233.1_Intron|ABHD14A_ENST00000491470.1_Missense_Mutation_p.G73V|ABHD14A_ENST00000273596.3_Missense_Mutation_p.G73V			Q03154	ACY1_HUMAN	aminoacylase 1	0					cellular amino acid metabolic process|proteolysis	cytosol	aminoacylase activity|metal ion binding|metallopeptidase activity			breast(1)|endometrium(1)|large_intestine(3)|lung(4)|ovary(1)|skin(1)	11				BRCA - Breast invasive adenocarcinoma(193;8.01e-05)|Kidney(197;0.000534)|KIRC - Kidney renal clear cell carcinoma(197;0.000716)	L-Aspartic Acid(DB00128)	GTCCTGGCTGGTCTCACCCCT	0.612													11	38	---	---	---	---
FAM86EP	348926	broad.mit.edu	37	4	3948505	3948505	+	RNA	SNP	G	G	A			TCGA-EJ-A7NH-01A-12D-A33T-08	TCGA-EJ-A7NH-10A-01D-A33W-08								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	4e69e7f2-9350-438e-b4c0-66d28d1681a3	ad22411c-0db0-4ad6-8c80-4134cc51e7ed	g.chr4:3948505G>A	ENST00000281228.8	-	0	880				FAM86EP_ENST00000313946.8_RNA																							CTAGCTCAGTGGTGAACAGCT	0.657													9	69	---	---	---	---
ZBTB12	221527	broad.mit.edu	37	6	31868519	31868519	+	Silent	SNP	T	T	C			TCGA-EJ-A7NH-01A-12D-A33T-08	TCGA-EJ-A7NH-10A-01D-A33W-08								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	4e69e7f2-9350-438e-b4c0-66d28d1681a3	ad22411c-0db0-4ad6-8c80-4134cc51e7ed	g.chr6:31868519T>C	ENST00000375527.2	-	2	739	c.564A>G	c.(562-564)gaA>gaG	p.E188E	C2_ENST00000469372.1_Intron	NM_181842.2	NP_862825.1	Q9Y330	ZBT12_HUMAN	zinc finger and BTB domain containing 12	188					regulation of transcription, DNA-dependent|transcription, DNA-dependent	nucleus	DNA binding|zinc ion binding			endometrium(2)|kidney(1)|lung(5)|prostate(1)|skin(1)	10						GCTCCAAGTCTTCATCCAGTG	0.622													3	46	---	---	---	---
COX7A2	1347	broad.mit.edu	37	6	75950898	75950898	+	Silent	SNP	C	C	T			TCGA-EJ-A7NH-01A-12D-A33T-08	TCGA-EJ-A7NH-10A-01D-A33W-08								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	4e69e7f2-9350-438e-b4c0-66d28d1681a3	ad22411c-0db0-4ad6-8c80-4134cc51e7ed	g.chr6:75950898C>T	ENST00000370081.2	-	3	508	c.198G>A	c.(196-198)ctG>ctA	p.L66L	COX7A2_ENST00000472311.2_Silent_p.L34L|COX7A2_ENST00000370089.2_Silent_p.L66L|COX7A2_ENST00000460985.1_Intron|COX7A2_ENST00000509698.1_Silent_p.L34L|COX7A2_ENST00000230459.4_Silent_p.L34L			P14406	CX7A2_HUMAN	cytochrome c oxidase subunit VIIa polypeptide 2 (liver)	34						mitochondrial respiratory chain	cytochrome-c oxidase activity|electron carrier activity			kidney(2)|lung(1)	3						GTACCTGGAACAGTTTTTGCT	0.348													15	130	---	---	---	---
TBX18	9096	broad.mit.edu	37	6	85446895	85446895	+	Silent	SNP	C	C	T			TCGA-EJ-A7NH-01A-12D-A33T-08	TCGA-EJ-A7NH-10A-01D-A33W-08								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	4e69e7f2-9350-438e-b4c0-66d28d1681a3	ad22411c-0db0-4ad6-8c80-4134cc51e7ed	g.chr6:85446895C>T	ENST00000369663.5	-	8	1669	c.1332G>A	c.(1330-1332)caG>caA	p.Q444Q	TBX18_ENST00000606784.1_Intron	NM_001080508.1	NP_001073977.1	O95935	TBX18_HUMAN	T-box 18	444					multicellular organismal development	nucleus	DNA binding|sequence-specific DNA binding transcription factor activity			NS(1)|breast(2)|endometrium(2)|kidney(1)|large_intestine(9)|liver(1)|lung(31)|ovary(2)|pancreas(3)|prostate(6)|skin(3)	61		all_cancers(76;0.000283)|Acute lymphoblastic leukemia(125;3.66e-08)|all_hematologic(105;8.61e-05)|all_epithelial(107;0.0858)		BRCA - Breast invasive adenocarcinoma(108;0.0267)		TCTCACCAGCCTGGTTGGTGA	0.607													12	60	---	---	---	---
DGKI	9162	broad.mit.edu	37	7	137237167	137237167	+	Missense_Mutation	SNP	C	C	T			TCGA-EJ-A7NH-01A-12D-A33T-08	TCGA-EJ-A7NH-10A-01D-A33W-08								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	4e69e7f2-9350-438e-b4c0-66d28d1681a3	ad22411c-0db0-4ad6-8c80-4134cc51e7ed	g.chr7:137237167C>T	ENST00000453654.2	-	20	1734	c.1195G>A	c.(1195-1197)Gcc>Acc	p.A399T	DGKI_ENST00000424189.2_Missense_Mutation_p.A699T|DGKI_ENST00000446122.1_Missense_Mutation_p.A699T|DGKI_ENST00000288490.5_Missense_Mutation_p.A699T			O75912	DGKI_HUMAN	diacylglycerol kinase, iota		DAGKc.				activation of protein kinase C activity by G-protein coupled receptor protein signaling pathway|intracellular signal transduction|platelet activation	nucleus|plasma membrane	ATP binding|diacylglycerol kinase activity|metal ion binding			breast(3)|cervix(1)|endometrium(6)|haematopoietic_and_lymphoid_tissue(1)|kidney(3)|large_intestine(12)|lung(46)|ovary(2)|prostate(4)|skin(4)|upper_aerodigestive_tract(1)|urinary_tract(1)	84						ACCATGTTGGCCTGATTCCTC	0.493													26	93	---	---	---	---
KMT2C	58508	broad.mit.edu	37	7	151873585	151873585	+	Nonsense_Mutation	SNP	G	G	A			TCGA-EJ-A7NH-01A-12D-A33T-08	TCGA-EJ-A7NH-10A-01D-A33W-08								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	4e69e7f2-9350-438e-b4c0-66d28d1681a3	ad22411c-0db0-4ad6-8c80-4134cc51e7ed	g.chr7:151873585G>A	ENST00000355193.2	-	38	9171	c.8953C>T	c.(8953-8955)Cag>Tag	p.Q2985*	KMT2C_ENST00000262189.6_Nonsense_Mutation_p.Q2985*					lysine (K)-specific methyltransferase 2C																		TGCACACCCTGAGAAAAAACA	0.473													7	44	---	---	---	---
TRPA1	8989	broad.mit.edu	37	8	72936047	72936047	+	Splice_Site	SNP	A	A	G			TCGA-EJ-A7NH-01A-12D-A33T-08	TCGA-EJ-A7NH-10A-01D-A33W-08								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	4e69e7f2-9350-438e-b4c0-66d28d1681a3	ad22411c-0db0-4ad6-8c80-4134cc51e7ed	g.chr8:72936047A>G	ENST00000262209.4	-	26	3357		c.e26+1		RP11-383H13.1_ENST00000457356.4_Intron|RP11-383H13.1_ENST00000537896.1_Intron|RP11-383H13.1_ENST00000524152.1_Intron	NM_007332.2	NP_015628.2	O75762	TRPA1_HUMAN	transient receptor potential cation channel, subfamily A, member 1							integral to plasma membrane				NS(1)|breast(2)|central_nervous_system(1)|endometrium(8)|haematopoietic_and_lymphoid_tissue(2)|kidney(3)|large_intestine(26)|lung(44)|ovary(4)|prostate(6)|stomach(1)	98			Epithelial(68;0.223)		Menthol(DB00825)	AAAAATACATACCGGTATTTC	0.244													11	51	---	---	---	---
APBA1	320	broad.mit.edu	37	9	72131101	72131101	+	Silent	SNP	C	C	T			TCGA-EJ-A7NH-01A-12D-A33T-08	TCGA-EJ-A7NH-10A-01D-A33W-08								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	4e69e7f2-9350-438e-b4c0-66d28d1681a3	ad22411c-0db0-4ad6-8c80-4134cc51e7ed	g.chr9:72131101C>T	ENST00000265381.4	-	2	1248	c.1026G>A	c.(1024-1026)aaG>aaA	p.K342K		NM_001163.3	NP_001154.2	Q02410	APBA1_HUMAN	amyloid beta (A4) precursor protein-binding, family A, member 1	342					axon cargo transport|cell adhesion|intracellular protein transport|nervous system development|protein complex assembly|synaptic transmission	synaptic vesicle				endometrium(4)|kidney(2)|large_intestine(12)|lung(13)|prostate(3)|skin(3)	37						TGGCATCGCGCTTCTCCTTGC	0.711													14	56	---	---	---	---
PFKM	5213	broad.mit.edu	37	12	48539011	48539011	+	Missense_Mutation	SNP	C	C	T			TCGA-EJ-A7NH-01A-12D-A33T-08	TCGA-EJ-A7NH-10A-01D-A33W-08								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	4e69e7f2-9350-438e-b4c0-66d28d1681a3	ad22411c-0db0-4ad6-8c80-4134cc51e7ed	g.chr12:48539011C>T	ENST00000340802.6	+	24	2548	c.2324C>T	c.(2323-2325)aCt>aTt	p.T775I	PFKM_ENST00000395233.2_Missense_Mutation_p.T673I|PFKM_ENST00000551804.1_Missense_Mutation_p.T673I|PFKM_ENST00000359794.5_Missense_Mutation_p.T704I|PFKM_ENST00000312352.7_Missense_Mutation_p.T704I|PFKM_ENST00000547587.1_Missense_Mutation_p.T704I	NM_001166686.1	NP_001160158.1	P08237	K6PF_HUMAN	phosphofructokinase, muscle	704					fructose 6-phosphate metabolic process|glycolysis|muscle cell homeostasis	6-phosphofructokinase complex|apical plasma membrane	6-phosphofructokinase activity|ATP binding|identical protein binding|kinase binding|metal ion binding|protein C-terminus binding			NS(3)|central_nervous_system(1)|cervix(1)|endometrium(2)|kidney(2)|large_intestine(4)|lung(16)|ovary(2)|prostate(2)|skin(1)|upper_aerodigestive_tract(1)	35						TTTGCCAATACTCCAGATTCG	0.542													14	79	---	---	---	---
CHD2	1106	broad.mit.edu	37	15	93524122	93524122	+	Missense_Mutation	SNP	G	G	C			TCGA-EJ-A7NH-01A-12D-A33T-08	TCGA-EJ-A7NH-10A-01D-A33W-08								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	4e69e7f2-9350-438e-b4c0-66d28d1681a3	ad22411c-0db0-4ad6-8c80-4134cc51e7ed	g.chr15:93524122G>C	ENST00000394196.4	+	23	4022	c.2954G>C	c.(2953-2955)gGg>gCg	p.G985A	CHD2_ENST00000557381.1_Missense_Mutation_p.G985A	NM_001271.3	NP_001262.3	O14647	CHD2_HUMAN	chromodomain helicase DNA binding protein 2	985	Glu-rich.				regulation of transcription from RNA polymerase II promoter	nucleus	ATP binding|ATP-dependent DNA helicase activity|DNA binding			breast(3)|endometrium(2)|haematopoietic_and_lymphoid_tissue(5)|kidney(2)|large_intestine(10)|lung(17)|ovary(1)|prostate(2)|skin(2)|stomach(1)|urinary_tract(2)	47	Lung NSC(78;0.00976)|all_lung(78;0.016)		BRCA - Breast invasive adenocarcinoma(143;0.0282)|OV - Ovarian serous cystadenocarcinoma(32;0.0814)			GAACTGGAAGGGGAGGAATCA	0.363													5	49	---	---	---	---
DLG4	1742	broad.mit.edu	37	17	7100327	7100327	+	Missense_Mutation	SNP	G	G	T			TCGA-EJ-A7NH-01A-12D-A33T-08	TCGA-EJ-A7NH-10A-01D-A33W-08								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	4e69e7f2-9350-438e-b4c0-66d28d1681a3	ad22411c-0db0-4ad6-8c80-4134cc51e7ed	g.chr17:7100327G>T	ENST00000399510.2	-	11	1813	c.961C>A	c.(961-963)Ctg>Atg	p.L321M	DLG4_ENST00000399506.2_Missense_Mutation_p.L278M|DLG4_ENST00000302955.6_Missense_Mutation_p.L275M	NM_001365.3	NP_001356.1	P78352	DLG4_HUMAN	discs, large homolog 4 (Drosophila)	278	PDZ 3.				axon guidance|learning|protein complex assembly|protein localization to synapse|signal transduction|synaptic transmission	cell junction|cortical cytoskeleton|endocytic vesicle membrane|neuron spine|postsynaptic density|postsynaptic membrane|synaptosome	protein binding|protein C-terminus binding			breast(1)|cervix(1)|endometrium(1)|kidney(1)|large_intestine(4)|lung(8)|ovary(2)	18						TCGGTGCCCAGGTAGCTGCTG	0.607													3	19	---	---	---	---
TP53	7157	broad.mit.edu	37	17	7578443	7578443	+	Missense_Mutation	SNP	A	A	G			TCGA-EJ-A7NH-01A-12D-A33T-08	TCGA-EJ-A7NH-10A-01D-A33W-08								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	4e69e7f2-9350-438e-b4c0-66d28d1681a3	ad22411c-0db0-4ad6-8c80-4134cc51e7ed	g.chr17:7578443A>G	ENST00000420246.2	-	5	619	c.487T>C	c.(487-489)Tac>Cac	p.Y163H	TP53_ENST00000455263.2_Missense_Mutation_p.Y163H|TP53_ENST00000359597.4_Missense_Mutation_p.Y163H|TP53_ENST00000445888.2_Missense_Mutation_p.Y163H|TP53_ENST00000413465.2_Missense_Mutation_p.Y163H|TP53_ENST00000269305.4_Missense_Mutation_p.Y163H	NM_001126114.2|NM_001276696.1	NP_001119586.1|NP_001263625.1	P04637	P53_HUMAN	tumor protein p53	163	Interaction with AXIN1 (By similarity).|Interaction with HIPK1 (By similarity).|Required for interaction with FBXO42.		Y -> C (in LFS; germline mutation and in sporadic cancers; somatic mutation).|Y -> D (in sporadic cancers; somatic mutation).|Y -> F (in a sporadic cancer; somatic mutation).|Y -> H (in sporadic cancers; somatic mutation).|Y -> N (in sporadic cancers; somatic mutation).|Y -> S (in sporadic cancers; somatic mutation).		activation of caspase activity by cytochrome c|base-excision repair|blood coagulation|cell cycle arrest|cell differentiation|cell proliferation|cellular protein localization|cellular response to drug|cellular response to glucose starvation|cellular response to hypoxia|cellular response to ionizing radiation|cellular response to UV|determination of adult lifespan|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest|DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis|DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator|ER overload response|interspecies interaction between organisms|negative regulation of apoptosis|negative regulation of cell growth|negative regulation of cell proliferation|negative regulation of helicase activity|negative regulation of transcription from RNA polymerase II promoter|nucleotide-excision repair|oxidative stress-induced premature senescence|positive regulation of histone deacetylation|positive regulation of neuron apoptosis|positive regulation of peptidyl-tyrosine phosphorylation|positive regulation of reactive oxygen species metabolic process|positive regulation of thymocyte apoptosis|positive regulation of transcription from RNA polymerase II promoter|protein localization|protein tetramerization|Ras protein signal transduction|regulation of mitochondrial membrane permeability|replicative senescence|response to antibiotic|response to gamma radiation|response to X-ray	cytoplasm|cytosol|endoplasmic reticulum|insoluble fraction|mitochondrion|nuclear chromatin|nuclear matrix|nucleolus|nucleus|PML body|protein complex|replication fork	ATP binding|chaperone binding|chromatin binding|copper ion binding|damaged DNA binding|DNA strand annealing activity|histone acetyltransferase binding|p53 binding|protease binding|protein binding|protein heterodimerization activity|protein kinase binding|protein N-terminus binding|protein phosphatase 2A binding|RNA polymerase II transcription factor binding|sequence-specific DNA binding transcription factor activity|transcription regulatory region DNA binding|transcription repressor activity|ubiquitin protein ligase binding|zinc ion binding	p.Y163N(20)|p.Y163H(17)|p.0?(8)|p.Y163D(5)|p.I162_Y163>N(3)|p.Y163fs*7(2)|p.V157_C176del20(1)|p.Y163fs*1(1)|p.Y163_Q165delYKQ(1)|p.P151_V173del23(1)|p.S149fs*72(1)|p.I30_Y31>N(1)|p.I162_Y163delIY(1)|p.I69_Y70>N(1)|p.Y70N(1)|p.A161fs*7(1)|p.Y31N(1)|p.Y163fs*14(1)|p.A159_Q167delAMAIYKQSQ(1)|p.Y163fs*18(1)|p.Y70D(1)|p.Y31D(1)		NS(16)|adrenal_gland(37)|autonomic_ganglia(16)|biliary_tract(273)|bone(108)|breast(2530)|central_nervous_system(1264)|cervix(68)|endometrium(223)|eye(24)|fallopian_tube(1)|gastrointestinal_tract_(site_indeterminate)(1)|genital_tract(16)|haematopoietic_and_lymphoid_tissue(1301)|kidney(96)|large_intestine(5124)|liver(897)|lung(2388)|meninges(5)|oesophagus(1473)|ovary(1659)|pancreas(452)|penis(10)|peritoneum(33)|pituitary(4)|placenta(1)|pleura(3)|prostate(235)|salivary_gland(43)|skin(791)|small_intestine(14)|soft_tissue(220)|stomach(1158)|testis(11)|thymus(21)|thyroid(54)|upper_aerodigestive_tract(2271)|urinary_tract(1259)|vagina(6)|vulva(79)	24185		all_cancers(10;1.01e-06)|Myeloproliferative disorder(207;0.0122)|Prostate(122;0.081)		GBM - Glioblastoma multiforme(2;1.59e-06)|READ - Rectum adenocarcinoma(115;0.174)		GACTGCTTGTAGATGGCCATG	0.622		111	"""Mis, N, F"""		"""breast, colorectal, lung, sarcoma, adrenocortical, glioma, multiple other tumour types"""	"""breast, sarcoma, adrenocortical carcinoma, glioma, multiple other tumour types"""		Other conserved DNA damage response genes	Osteosarcoma, Familial Clustering of;Li-Fraumeni syndrome;Hereditary Breast-Ovarian Cancer, non-BRCA1/2;Hereditary Adrenocortical Cancer;Endometrial Cancer, Familial Clustering of	HNSCC(1;<9.43e-08)|TCGA GBM(1;<1E-08)|TSP Lung(2;<1E-08)|TCGA Ovarian(1;<1.89e-07)|Multiple Myeloma(5;0.019)			5	54	---	---	---	---
BAGE2	85319	broad.mit.edu	37	21	11047546	11047546	+	RNA	SNP	C	C	A			TCGA-EJ-A7NH-01A-12D-A33T-08	TCGA-EJ-A7NH-10A-01D-A33W-08								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	4e69e7f2-9350-438e-b4c0-66d28d1681a3	ad22411c-0db0-4ad6-8c80-4134cc51e7ed	g.chr21:11047546C>A	ENST00000470054.1	-	0	708									B melanoma antigen family, member 2															Colorectal(6;3.44e-05)|COAD - Colon adenocarcinoma(6;0.00727)|READ - Rectum adenocarcinoma(6;0.0723)	UCEC - Uterine corpus endometrioid carcinoma (6;0.0974)|all cancers(6;2.54e-22)|Epithelial(6;4.21e-19)|OV - Ovarian serous cystadenocarcinoma(6;1.16e-09)|BRCA - Breast invasive adenocarcinoma(6;7.72e-05)|Lung(8;0.000189)|LUSC - Lung squamous cell carcinoma(6;0.00379)|GBM - Glioblastoma multiforme(6;0.00391)|Kidney(17;0.0773)|LUAD - Lung adenocarcinoma(8;0.247)		GTATGATACCCTTTGTCACAC	0.338													5	475	---	---	---	---
EIF3L	51386	broad.mit.edu	37	22	38254723	38254723	+	Nonsense_Mutation	SNP	C	C	G			TCGA-EJ-A7NH-01A-12D-A33T-08	TCGA-EJ-A7NH-10A-01D-A33W-08								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	4e69e7f2-9350-438e-b4c0-66d28d1681a3	ad22411c-0db0-4ad6-8c80-4134cc51e7ed	g.chr22:38254723C>G	ENST00000412331.2	+	5	993	c.411C>G	c.(409-411)taC>taG	p.Y137*	EIF3L_ENST00000476955.1_Intron|EIF3L_ENST00000406934.1_Nonsense_Mutation_p.Y39*|EIF3L_ENST00000381683.6_Nonsense_Mutation_p.Y137*	NM_016091.3	NP_057175.1	Q9Y262	EIF3L_HUMAN	eukaryotic translation initiation factor 3, subunit L	137						eukaryotic translation initiation factor 3 complex	protein binding|translation initiation factor activity			kidney(2)|large_intestine(3)|lung(4)|ovary(2)|skin(2)|upper_aerodigestive_tract(1)|urinary_tract(1)	15						AATTATACTACAGGCACATAT	0.368													35	167	---	---	---	---
